Prospective Study of Drug-induced Interstitial Lung Disease in Advanced Breast Cancer Patients Receiving Everolimus Plus Exemestane

BACKGROUND: Everolimus-related interstitial lung disease (ILD) (also: pneumonitis) poses a difficulty for physicians, as it is hard to discriminate ILD from other causes of respiratory symptoms and to decide on safe treatment continuation. OBJECTIVE: We investigated the capability of pulmonary funct...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Target Oncol
Autors principals: Willemsen, Annelieke E. C. A. B., Tol, Jolien, van Erp, Nielka P., Jonker, Marianne A., de Boer, Maaike, Meek, Bob, de Jong, Paul C., van Moorsel, Coline, Gerritsen, Winald R., Grutters, Jan C., van Herpen, Carla M. L.
Format: Artigo
Idioma:Inglês
Publicat: Springer International Publishing 2019
Matèries:
Original Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6684805/
https://ncbi.nlm.nih.gov/pubmed/31325105
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11523-019-00656-2
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars